drugset
drugset / Trial / NCT01430312

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

NCT01430312 ↗

Phase 1 Completed 40 enrolled LEO Pharma Bayer · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to determine the irritancy potential of azelaic acid pre-foam formulation.

Timeline

Start
2011-09
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule — Topical
Comparator Sodium Lauryl Sulfate Small molecule 0.5 % Topical

Indications

No indication recorded.